Similarly, ATM-AVI was active against isolates from infection sources (MIC90 0.5–4 μg/mL) with ≥90.9% of isolates inhibited by ATM-AVI at ≤8 μg/mL globally and across regions (data limited to small number of isolates in North America (n ≤ 18)) (Table 5 and Table S9). The gene discussed is ATM; the disease is infection.